Back to
Cubist Systematic Strategies, LLC
RYTM
Showing 3 of 18 quarters
Position history for
Cubist Systematic Strategies, LLC's holdings in Rhythm Pharmaceuticals, Inc.
No. Cubist Systematic Strategies exited its RYTM (Rhythm Pharmaceuticals) position in Q3 2025. Its Q2 2025 13F listed 64,577 shares worth $4.1M. Cubist Systematic Strategies first reported RYTM in Q2 2019 and held it in 12 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$9.2M
Total Shares Change
-173,822
Quarter-by-Quarter History